(Q53989640)

23 May 2018

title

An open, multicenter clinical trial of piperacillin/tazobactam in the treatment of pediatric patients with intra-abdominal infections. (English)

1 reference

23 May 2018

multicenter clinical trial

main subject

1 reference

based on heuristic

inferred from title

piperacillin/tazobactam

1 reference

A Arguedas

1

1 reference

23 May 2018

J Sifuentes-Osornio

2

1 reference

23 May 2018

C Loaiza

3

1 reference

23 May 2018

M Herrera

4

1 reference

23 May 2018

J C Corrales

5

1 reference

23 May 2018

E Mohs

6

1 reference

23 May 2018

publication date

1 April 1996

1 reference

23 May 2018

published in

Journal of Chemotherapy

1 reference

23 May 2018

volume

8

1 reference

23 May 2018

issue

2

1 reference

23 May 2018

page(s)

130-136

1 reference

23 May 2018

Intraabdominal infections

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.2.130

Wound and intraabdominal infections: microbiological considerations and approaches to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.2.130

Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.2.130

Comparison of the safety and efficacy of parenteral ticarcillin/clavulanate and clindamycin/gentamicin in serious intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.2.130

A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.2.130

Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.2.130

Piperacillin therapy for serious bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.2.130

Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.2.130

In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.2.130

Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.2.130

21 January 2018

Identifiers

DOI

10.1179/JOC.1996.8.2.130

1 reference

23 May 2018

1 reference

23 May 2018